Home
Conditions
Leukemia, B-Cell

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Not Yet Recruiting

Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT07557056

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Not Yet Recruiting

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies

NCT07679919

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: Taussig Cancer Institute | Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Not Yet Recruiting

A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia

NCT07674810

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

NCT07592481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors

NCT07526597

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Not Yet Recruiting

Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT07582159

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Not Yet Recruiting

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

NCT07520006

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway

NCT07463976

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: The Royal Wolverhampton NHS Trust Wolverhampton, United Kingdom

View Trial Details

Not Yet Recruiting

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

NCT07516093

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

NCT07508995

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Leukemia, B-Cell

Leukemia, B-Cell trial results

Related conditions